EX-16.1 2 ex16_1march162012.htm PROGENICS EXHIBIT 16.1 MARCH 16, 2012 ex16_1march162012.htm


 
                                           EXHIBIT 16.1
 

 
March 16, 2012
 
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
 
Commissioners:
 
We have read the statements made by Progenics Pharmaceuticals, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Progenics Pharmaceuticals, Inc. dated March 16, 2012. We agree with the statements concerning our Firm in such Form 8-K.
 
Very truly yours,
 
/s/ PricewaterhouseCoopers LLP